These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29957042)

  • 21. Behavioural implications of traditional treatment and closed-loop automated insulin delivery systems in Type 1 diabetes: applying a cognitive restraint theory framework.
    Kahkoska AR; Mayer-Davis EJ; Hood KK; Maahs DM; Burger KS
    Diabet Med; 2017 Nov; 34(11):1500-1507. PubMed ID: 28626906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minimed 670G: a hybrid closed-loop insulin delivery system.
    Med Lett Drugs Ther; 2016 Nov; 58(1508):147-148. PubMed ID: 27849192
    [No Abstract]   [Full Text] [Related]  

  • 23. Open Source Closed-Loop Insulin Delivery Systems: A Clash of Cultures or Merging of Diverse Approaches?
    Barnard KD; Ziegler R; Klonoff DC; Braune K; Petersen B; Rendschmidt T; Finan D; Kowalski A; Heinemann L
    J Diabetes Sci Technol; 2018 Nov; 12(6):1223-1226. PubMed ID: 30079769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Closed loop insulin delivery in diabetes.
    Battelino T; Omladič JŠ; Phillip M
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):315-25. PubMed ID: 26051293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced burden of diabetes and improved quality of life: Experiences from unrestricted day-and-night hybrid closed-loop use in very young children with type 1 diabetes.
    Musolino G; Dovc K; Boughton CK; Tauschmann M; Allen JM; Nagl K; Fritsch M; Yong J; Metcalfe E; Schaeffer D; Fichelle M; Schierloh U; Thiele AG; Abt D; Kojzar H; Mader JK; Slegtenhorst S; Ashcroft N; Wilinska ME; Sibayan J; Cohen N; Kollman C; Hofer SE; Fröhlich-Reiterer E; Kapellen TM; Acerini CL; de Beaufort C; Campbell F; Rami-Merhar B; Hovorka R;
    Pediatr Diabetes; 2019 Sep; 20(6):794-799. PubMed ID: 31140654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin Pump Therapy: Patient Practices and Glycemic Outcomes.
    Edem D; McCarthy P; Ng JM; Stefanovic-Racic M; Korytkowski MT
    J Diabetes Sci Technol; 2018 Nov; 12(6):1250-1251. PubMed ID: 29808716
    [No Abstract]   [Full Text] [Related]  

  • 27. Insulin Infusion Sets and Continuous Glucose Monitoring Sensors: Where the Artificial Pancreas Meets the Patient.
    Forlenza GP
    Diabetes Technol Ther; 2017 Apr; 19(4):206-208. PubMed ID: 28418732
    [No Abstract]   [Full Text] [Related]  

  • 28. Artificial Pancreas Device Systems for the Closed-Loop Control of Type 1 Diabetes: What Systems Are in Development?
    Trevitt S; Simpson S; Wood A
    J Diabetes Sci Technol; 2016 May; 10(3):714-23. PubMed ID: 26589628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Closing the Loop on Managing Youth With Type 1 Diabetes: Children Are Not Just Small Adults.
    Sherr JL
    Diabetes Care; 2018 Aug; 41(8):1572-1578. PubMed ID: 29936422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensor-Augmented Pump-Based Customized Mathematical Model for Type 1 Diabetes.
    Grosman B; Wu D; Miller D; Lintereur L; Roy A; Parikh N; Kaufman FR
    Diabetes Technol Ther; 2018 Mar; 20(3):207-221. PubMed ID: 29565722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
    Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
    Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluctuations of Hyperglycemia and Insulin Sensitivity Are Linked to Menstrual Cycle Phases in Women With T1D.
    Brown SA; Jiang B; McElwee-Malloy M; Wakeman C; Breton MD
    J Diabetes Sci Technol; 2015 Oct; 9(6):1192-9. PubMed ID: 26468135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis.
    Nimri R; Muller I; Atlas E; Miller S; Kordonouri O; Bratina N; Tsioli C; Stefanija MA; Danne T; Battelino T; Phillip M
    Pediatr Diabetes; 2014 Mar; 15(2):91-9. PubMed ID: 23944875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery.
    Dovc K; Boughton C; Tauschmann M; Thabit H; Bally L; Allen JM; Acerini CL; Arnolds S; de Beaufort C; Bergenstal RM; Campbell F; Criego A; Dunger DB; Elleri D; Evans ML; Fröhlich-Reiterer E; Hofer S; Kapellen T; Leelarathna L; Pieber TR; Rami-Merhar B; Shah VN; Sibayan J; Wilinska ME; Hovorka R;
    Diabetes Care; 2019 Jul; 42(7):1344-1347. PubMed ID: 31221700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The closed-loop artificial pancreas in 2020.
    Fabris C; Kovatchev B
    Artif Organs; 2020 Jul; 44(7):671-679. PubMed ID: 32384582
    [No Abstract]   [Full Text] [Related]  

  • 36. Artificial pancreas: an emerging approach to treat Type 1 diabetes.
    Kumareswaran K; Evans ML; Hovorka R
    Expert Rev Med Devices; 2009 Jul; 6(4):401-10. PubMed ID: 19572795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity of the Predictive Hypoglycemia Minimizer System to the Algorithm Aggressiveness Factor.
    Finan DA; Dassau E; Breton MD; Patek SD; McCann TW; Kovatchev BP; Doyle FJ; Levy BL; Venugopalan R
    J Diabetes Sci Technol; 2015 Jun; 10(1):104-10. PubMed ID: 26134834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychosocial impacts of hybrid closed-loop systems in the management of diabetes: a review.
    Farrington C
    Diabet Med; 2018 Apr; 35(4):436-449. PubMed ID: 29247547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expectations and Attitudes of Individuals With Type 1 Diabetes After Using a Hybrid Closed Loop System.
    Iturralde E; Tanenbaum ML; Hanes SJ; Suttiratana SC; Ambrosino JM; Ly TT; Maahs DM; Naranjo D; Walders-Abramson N; Weinzimer SA; Buckingham BA; Hood KK
    Diabetes Educ; 2017 Apr; 43(2):223-232. PubMed ID: 28340542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in closed-loop insulin delivery.
    Ware J; Hovorka R
    Metabolism; 2022 Feb; 127():154953. PubMed ID: 34890648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.